US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 8.350
  • +0.260+3.21%
Close Apr 26 16:00 ET
  • 8.270
  • -0.080-0.96%
Post 18:36 ET
809.07MMarket Cap-14649P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.07

+54.43%
Analyst Rating

Strong Buy

Mar 31, 2024

ARS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q210.000K / 0.000--
--2023/Q120.000K / 0.000--
--2022/Q40.000 / 100.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q210.000K / 0.000--
--2023/Q120.000K / 0.000--
--2022/Q40.000 / 100.000K--
--------
--------
--------

Unlock Free Earnings Estimates

ARS Pharmaceuticals Earnings Reports

  • ARS Pharmaceuticals | 10-K: Annual report

    Mar 21 22:22 ET

  • ARS Pharmaceuticals | 10-Q: Quarterly report

    Nov 9, 2023 16:04 ET

  • ARS Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:08 ET

  • ARS Pharmaceuticals | 10-Q: Quarterly report

    May 15, 2023 09:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg